Utilizing the triglyceride-glucose index alongside innovative anthropometric indicators to assess mortality risk in individuals with type 2 diabetes: a prospective cohort analysis - Report - DentalSpire

Utilizing the triglyceride-glucose index alongside innovative anthropometric indicators to assess mortality risk in individuals with type 2 diabetes: a prospective cohort analysis

  • By

  • Yining Wang

  • Fei Wu

  • Hongfei Mo

  • Qinghua Yan

  • Hongjie Chu

  • Mengyan Wang

  • Yang Zhou

  • Huiting Yu

  • Shuyue Sun

  • Minna Cheng

  • Fan Wang

  • Yan Shi

  • January 16, 2026

  • 0 min

Share

Clinical Report: Utilizing the triglyceride-glucose index to assess mortality risk

Overview

This study evaluates the association between the triglyceride-glucose (TyG) index and mortality risk in elderly Chinese patients with type 2 diabetes mellitus (T2DM). It highlights the potential of composite indices combining TyG with innovative anthropometric measures to enhance risk stratification.

Background

Diabetes, particularly type 2 diabetes mellitus (T2DM), poses significant global health challenges, contributing to high morbidity and mortality rates. Accurate assessment of mortality risk is crucial for effective management and intervention strategies. Traditional measures of insulin resistance and obesity have limitations, necessitating the exploration of novel indices that may better predict outcomes in diabetic populations.

Data Highlights

No specific numerical data provided in the article.

Key Findings

  • The TyG index is a reliable surrogate marker for insulin resistance and mortality risk in T2DM patients.
  • Composite indices combining TyG with novel anthropometric measures may provide superior prognostic value.
  • Renal dysfunction, indicated by decreased eGFR, mediates the relationship between insulin resistance and mortality risk.
  • Traditional obesity measures like BMI and WC have limitations that novel indicators aim to address.
  • Older adults with T2DM show a heightened mortality risk, underscoring the need for effective risk assessment tools.

Clinical Implications

Detail practical implementation strategies for the TyG index in clinical practice.

Conclusion

The study underscores the importance of utilizing composite indices for mortality risk assessment in T2DM, potentially improving clinical outcomes through enhanced risk stratification.

References

  1. Frontiers in Endocrinology, 2026 -- Beyond the triglyceride-glucose index, the cholesterol-high-density lipoprotein-glucose index as a superior predictor for diabetes risk
  2. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Association of Triglyceride-Glucose Index with Mortality Risk in a Large Italian Cohort (URRAH Study)
  3. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Assessing 1-Hour Postload Glucose Levels for Early Detection of Type 2 Diabetes Risk
  4. The Journal of Clinical Endocrinology & Metabolism, 2025 -- Links Between Regional Fat Distribution and Cardiovascular Disease Risk and Mortality in Type 2 Diabetes Patients
  5. Standards of Care in Diabetes—2026 - PMC
  6. Triglyceride-Glucose Index and Mortality Risk in the General Population: A Systematic Review and Meta-analysis
  7. The long term association of nine anthropometric obesity indices with cardiovascular diseases and mortality
  8. Summary of Revisions: Standards of Care in Diabetes—2026 - PMC
  9. Triglyceride-Glucose Index and Mortality Risk in the General Population: A Systematic Review and Meta-analysis of Prospective Studies | High Blood Pressure & Cardiovascular Prevention | Springer Nature Link
  10. The long term association of nine anthropometric obesity indices with cardiovascular diseases and mortality | Scientific Reports

Original Source(s)

Related Content